Novartis Czech Republic was established as a successor to Ciba-Geigy Ltd. and Sandoz AG on 26.2.1997. The current name of our company in the Czech Republic is Novartis s.r.o. and registered office is based on Na Pankráci 1724/129, Prague 4. Novartis s.r.o. is part of the Novartis concern. The Novartis Group includes Sandoz and Alcon, which have also offices in Prague.
In the Czech Republic, Novartis employs approximately 860 employees within the Innovative Medicines Division, Alcon, Sandoz, and the global Novartis Business Services Service Center.
Structure of Novartis s.r.o. The Innovative Medicines Division, focusing on innovative, innovative treatments, is divided into two Business Units: Pharmaceuticals and Oncology.
The history of the company can be traced back to the middle of the 19th century, when the three companies that would go on to form Novartis (Ciba, Geigy and Sandoz) were established. Novartis was formed in 1996 when Sandoz joined with the already merged Ciba-Geigy.